Cotinga Pharmaceuticals Год IPO
Что обозначает Год IPO в Cotinga Pharmaceuticals?
Год IPO Cotinga Pharmaceuticals, Inc. является 2007
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на TSXV по сравнению с Cotinga Pharmaceuticals
Что делает Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Компании с год ipo похож на Cotinga Pharmaceuticals
- G3 Exploration имеет Год IPO из 2006
- Evolis SA имеет Год IPO из 2006
- Unity Infraprojects имеет Год IPO из 2006
- News Invest имеет Год IPO из 2006
- AuStar Gold имеет Год IPO из 2006
- Sky and Space Global имеет Год IPO из 2006
- Cotinga Pharmaceuticals имеет Год IPO из 2007
- Manas Resources имеет Год IPO из 2008
- Mastech Digital Inc имеет Год IPO из 2008
- MYR Inc имеет Год IPO из 2008
- Dana Inc имеет Год IPO из 2008
- American Water Works Co имеет Год IPO из 2008
- Chromadex Corp имеет Год IPO из 2008